APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Imaging CRO

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Molecular Imaging CRO Market Outlook and Growth Opportunities 2026

4 June 2026197 pages

Choose your research edition.

Industry ResearchMolecular Imaging CRO Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Imaging CRO Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Molecular Imaging CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Imaging CRO Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Imaging CRO Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Molecular Imaging CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Molecular Imaging CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Imaging CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Imaging CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Molecular Imaging CRO market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Molecular Imaging CRO market include BioPharma Services, Bruker, Charles River, Enigma Biomedical Group, Imaging Endpoints, Micron, Inc, Minerva Imaging and Oncodesign Services, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Molecular Imaging CRO market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Imaging CRO and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Imaging CRO revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Molecular Imaging CRO market.

Molecular Imaging CRO Segment by Company

BioPharma Services

Bruker

Charles River

Enigma Biomedical Group

Imaging Endpoints

Micron, Inc

Minerva Imaging

Oncodesign Services

Molecular Imaging CRO Segment by Type

Radionuclide Molecular Imaging

Optical Molecular Imaging

Magnetic Resonance Molecular Imaging

Molecular Imaging CRO Segment by Application

Drug Development

Cancer Treatment

Others

Molecular Imaging CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Molecular Imaging CRO status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Molecular Imaging CRO key companies, revenue, market share, and recent developments.

3. To split the Molecular Imaging CRO breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Molecular Imaging CRO market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molecular Imaging CRO significant trends, drivers, influence factors in global and regions.

6. To analyze Molecular Imaging CRO competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Imaging CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Imaging CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Imaging CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Imaging CRO industry.

Chapter 3: Detailed analysis of Molecular Imaging CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Molecular Imaging CRO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Molecular Imaging CRO in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molecular Imaging CRO Industry Trends Table 2. Molecular Imaging CRO Industry Drivers Table 3. Molecular Imaging CRO Industry Opportunities and Challenges Table 4. Molecular Imaging CRO Industry Restraints Table 5. Global Molecular Imaging CRO Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molecular Imaging CRO Revenue Share by Company (2021-2026) Table 7. Global Molecular Imaging CRO Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Molecular Imaging CRO Key Company Manufacturing Base & Headquarters Table 9. Global Molecular Imaging CRO Company, Product Type & Application Table 10. Global Molecular Imaging CRO Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Molecular Imaging CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Radionuclide Molecular Imaging Table 15. Significant Companies of Optical Molecular Imaging Table 16. Significant Companies of Magnetic Resonance Molecular Imaging Table 17. Global Molecular Imaging CRO Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Molecular Imaging CRO Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Molecular Imaging CRO Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Molecular Imaging CRO Sales Value Share by Type (2021-2026) Table 21. Global Molecular Imaging CRO Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Drug Development Table 23. Significant Companies of Cancer Treatment Table 24. Significant Companies of Others Table 25. Global Molecular Imaging CRO Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Molecular Imaging CRO Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Molecular Imaging CRO Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Molecular Imaging CRO Sales Value Share by Application (2021-2026) Table 29. Global Molecular Imaging CRO Sales Value Share by Application (2027-2032) Table 30. Global Molecular Imaging CRO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Molecular Imaging CRO Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Molecular Imaging CRO Sales Value Share by Region (2021-2026) Table 33. Global Molecular Imaging CRO Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Molecular Imaging CRO Sales Value Share by Region (2027-2032) Table 35. Global Molecular Imaging CRO Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Molecular Imaging CRO Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Molecular Imaging CRO Sales Value Market Share by Country (2021-2026) Table 38. Global Molecular Imaging CRO Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Molecular Imaging CRO Sales Value Market Share by Country (2027-2032) Table 40. BioPharma Services Company Information Table 41. BioPharma Services Business Overview Table 42. BioPharma Services Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. BioPharma Services Molecular Imaging CRO Product Portfolio Table 44. BioPharma Services Recent Development Table 45. Bruker Company Information Table 46. Bruker Business Overview Table 47. Bruker Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Bruker Molecular Imaging CRO Product Portfolio Table 49. Bruker Recent Development Table 50. Charles River Company Information Table 51. Charles River Business Overview Table 52. Charles River Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Charles River Molecular Imaging CRO Product Portfolio Table 54. Charles River Recent Development Table 55. Enigma Biomedical Group Company Information Table 56. Enigma Biomedical Group Business Overview Table 57. Enigma Biomedical Group Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Enigma Biomedical Group Molecular Imaging CRO Product Portfolio Table 59. Enigma Biomedical Group Recent Development Table 60. Imaging Endpoints Company Information Table 61. Imaging Endpoints Business Overview Table 62. Imaging Endpoints Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Imaging Endpoints Molecular Imaging CRO Product Portfolio Table 64. Imaging Endpoints Recent Development Table 65. Micron, Inc Company Information Table 66. Micron, Inc Business Overview Table 67. Micron, Inc Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Micron, Inc Molecular Imaging CRO Product Portfolio Table 69. Micron, Inc Recent Development Table 70. Minerva Imaging Company Information Table 71. Minerva Imaging Business Overview Table 72. Minerva Imaging Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Minerva Imaging Molecular Imaging CRO Product Portfolio Table 74. Minerva Imaging Recent Development Table 75. Oncodesign Services Company Information Table 76. Oncodesign Services Business Overview Table 77. Oncodesign Services Molecular Imaging CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Oncodesign Services Molecular Imaging CRO Product Portfolio Table 79. Oncodesign Services Recent Development Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Molecular Imaging CRO Product Image Figure 2. Global Molecular Imaging CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Imaging CRO Market Size (2021-2032) & (US$ Million) Figure 4. Global Molecular Imaging CRO Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Radionuclide Molecular Imaging Image Figure 8. Optical Molecular Imaging Image Figure 9. Magnetic Resonance Molecular Imaging Image Figure 10. Global Molecular Imaging CRO Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Molecular Imaging CRO Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Molecular Imaging CRO Sales Value Share by Type (2021-2032) Figure 13. Drug Development Image Figure 14. Cancer Treatment Image Figure 15. Others Image Figure 16. Global Molecular Imaging CRO Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Molecular Imaging CRO Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Molecular Imaging CRO Sales Value Share by Application (2021-2032) Figure 19. Global Molecular Imaging CRO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Molecular Imaging CRO Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Molecular Imaging CRO Sales Value (2021-2032) & (US$ Million) Figure 22. North America Molecular Imaging CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Molecular Imaging CRO Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Molecular Imaging CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Molecular Imaging CRO Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Molecular Imaging CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Molecular Imaging CRO Sales Value (2021-2032) & (US$ Million) Figure 28. South America Molecular Imaging CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Molecular Imaging CRO Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Molecular Imaging CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Molecular Imaging CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Radionuclide Molecular Imaging
  • Optical Molecular Imaging
  • Magnetic Resonance Molecular Imaging
Applications
  • Drug Development
  • Cancer Treatment
  • Others
Companies covered
  • BioPharma Services
  • Bruker
  • Charles River
  • Enigma Biomedical Group
  • Imaging Endpoints
  • Micron, Inc
  • Minerva Imaging
  • Oncodesign Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Molecular Imaging CRO Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Molecular Imaging CRO Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Molecular Imaging CRO Market Dynamics
  1. 2.1 Molecular Imaging CRO Industry Trends
  2. 2.2 Molecular Imaging CRO Industry Drivers
  3. 2.3 Molecular Imaging CRO Industry Opportunities and Challenges
  4. 2.4 Molecular Imaging CRO Industry Restraints
3 Molecular Imaging CRO Market by Company
  1. 3.1 Global Molecular Imaging CRO Company Revenue Ranking in 2025
  2. 3.2 Global Molecular Imaging CRO Revenue by Company (2021-2026)
  3. 3.3 Global Molecular Imaging CRO Company Ranking (2024-2026)
  4. 3.4 Global Molecular Imaging CRO Company Manufacturing Base and Headquarters
  5. 3.5 Global Molecular Imaging CRO Company Product Type and Application
  6. 3.6 Global Molecular Imaging CRO Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Molecular Imaging CRO Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Molecular Imaging CRO Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Molecular Imaging CRO Market by Type
  1. 4.1 Molecular Imaging CRO Type Introduction
  2. 4.1.1 Radionuclide Molecular Imaging
  3. 4.1.2 Optical Molecular Imaging
  4. 4.1.3 Magnetic Resonance Molecular Imaging
  5. 4.2 Global Molecular Imaging CRO Sales Value by Type
  6. 4.2.1 Global Molecular Imaging CRO Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Molecular Imaging CRO Sales Value by Type (2021-2032)
  8. 4.2.3 Global Molecular Imaging CRO Sales Value Share by Type (2021-2032)
5 Molecular Imaging CRO Market by Application
  1. 5.1 Molecular Imaging CRO Application Introduction
  2. 5.1.1 Drug Development
  3. 5.1.2 Cancer Treatment
  4. 5.1.3 Others
  5. 5.2 Global Molecular Imaging CRO Sales Value by Application
  6. 5.2.1 Global Molecular Imaging CRO Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Molecular Imaging CRO Sales Value by Application (2021-2032)
  8. 5.2.3 Global Molecular Imaging CRO Sales Value Share by Application (2021-2032)
6 Molecular Imaging CRO Regional Value Analysis
  1. 6.1 Global Molecular Imaging CRO Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Imaging CRO Sales Value by Region (2021-2032)
  3. 6.2.1 Global Molecular Imaging CRO Sales Value by Region: 2021-2026
  4. 6.2.2 Global Molecular Imaging CRO Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Molecular Imaging CRO Sales Value (2021-2032)
  7. 6.3.2 North America Molecular Imaging CRO Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Molecular Imaging CRO Sales Value (2021-2032)
  10. 6.4.2 Europe Molecular Imaging CRO Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Molecular Imaging CRO Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Molecular Imaging CRO Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Molecular Imaging CRO Sales Value (2021-2032)
  16. 6.6.2 South America Molecular Imaging CRO Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Molecular Imaging CRO Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Molecular Imaging CRO Sales Value Share by Country, 2025 VS 2032
7 Molecular Imaging CRO Country-level Value Analysis
  1. 7.1 Global Molecular Imaging CRO Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molecular Imaging CRO Sales Value by Country (2021-2032)
  3. 7.2.1 Global Molecular Imaging CRO Sales Value by Country (2021-2026)
  4. 7.2.2 Global Molecular Imaging CRO Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Molecular Imaging CRO Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Molecular Imaging CRO Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Molecular Imaging CRO Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BioPharma Services
  2. 8.1.1 BioPharma Services Company Information
  3. 8.1.2 BioPharma Services Business Overview
  4. 8.1.3 BioPharma Services Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BioPharma Services Molecular Imaging CRO Product Portfolio
  6. 8.1.5 BioPharma Services Recent Developments
  7. 8.2 Bruker
  8. 8.2.1 Bruker Company Information
  9. 8.2.2 Bruker Business Overview
  10. 8.2.3 Bruker Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bruker Molecular Imaging CRO Product Portfolio
  12. 8.2.5 Bruker Recent Developments
  13. 8.3 Charles River
  14. 8.3.1 Charles River Company Information
  15. 8.3.2 Charles River Business Overview
  16. 8.3.3 Charles River Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Charles River Molecular Imaging CRO Product Portfolio
  18. 8.3.5 Charles River Recent Developments
  19. 8.4 Enigma Biomedical Group
  20. 8.4.1 Enigma Biomedical Group Company Information
  21. 8.4.2 Enigma Biomedical Group Business Overview
  22. 8.4.3 Enigma Biomedical Group Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Enigma Biomedical Group Molecular Imaging CRO Product Portfolio
  24. 8.4.5 Enigma Biomedical Group Recent Developments
  25. 8.5 Imaging Endpoints
  26. 8.5.1 Imaging Endpoints Company Information
  27. 8.5.2 Imaging Endpoints Business Overview
  28. 8.5.3 Imaging Endpoints Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Imaging Endpoints Molecular Imaging CRO Product Portfolio
  30. 8.5.5 Imaging Endpoints Recent Developments
  31. 8.6 Micron, Inc
  32. 8.6.1 Micron, Inc Company Information
  33. 8.6.2 Micron, Inc Business Overview
  34. 8.6.3 Micron, Inc Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Micron, Inc Molecular Imaging CRO Product Portfolio
  36. 8.6.5 Micron, Inc Recent Developments
  37. 8.7 Minerva Imaging
  38. 8.7.1 Minerva Imaging Company Information
  39. 8.7.2 Minerva Imaging Business Overview
  40. 8.7.3 Minerva Imaging Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Minerva Imaging Molecular Imaging CRO Product Portfolio
  42. 8.7.5 Minerva Imaging Recent Developments
  43. 8.8 Oncodesign Services
  44. 8.8.1 Oncodesign Services Company Information
  45. 8.8.2 Oncodesign Services Business Overview
  46. 8.8.3 Oncodesign Services Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Oncodesign Services Molecular Imaging CRO Product Portfolio
  48. 8.8.5 Oncodesign Services Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst